#RBIPolicy Poll | The MPC of @RBI is set to announce its policy decision at 10 am today amid rising #COVID cases and elevated inflation. MPC is expected to maintain status quo in this policy & the focus will shift towards RBI's stance on liquidity management and forward guidance Image
#RBIPolicy Poll | Most bankers believe, @RBI will maintain its #GDP forecast for FY21 & FY22 Image
#RBIPolicy Poll | As per CNBC-TV18 poll, 60% of bankers see @RBI retaining CPI inflation forecast of 5-5.2% for H1FY22 Image
#RBIPolicy Poll | Majority of the bankers expect MPC to retain 'accommodative' stance. Also, 40% of them expect @RBI to be more dovish than the last policy Image

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with CNBC-TV18

CNBC-TV18 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @CNBCTV18Live

9 Apr
#MarketAtClose | Financials remain a drag; Nifty Bank falls 1% vs 0.3% for Sensex & #Nifty

#Pharma lends support with the leading index gaining more than 3%

#Sensex falls 155 points to 49,591 & Nifty 39 points to 14,835 Image
#MarketAtClose | Nifty Banks slips 335 pts to 32,448 while midcap index rises 43 pts to 24,506

Cipla, Sun Pharma, HUL, Tech Mahindra & Wipro top index gainers

Reliance, ICICI Bank & HDFC Bank drag nifty by 44 points
#MarketAtClose | ICICI Bank & HDFC Bank contribute nearly 80% to Nifty Bank fall

Demand rise for remdesivir lifts pharma stocks such as Cadila, Cipla & Jubilant Image
Read 6 tweets
9 Apr
#CNBCTV18Market | CLSA maintains BUY call on NTPC, target at Rs 150/sh Image
#CNBCTV18Market | CLSA says the uptick in cement prices is fairly priced in, further uptick hinges on earnings trajectory. Profitablity of cement cos would be key, given the expensive valuations Image
#CNBCTV18Market | Jefferies says the building materials sector is on-course to report another strong quarter Image
Read 6 tweets
8 Apr
#MarketAtClose | Metals IT & Cement Shine While Financials Drag Market

Financials Drag Nifty By 19 Points While IT Lifts By 22 Points

Nifty Slips 110 Points, Sensex 372 Points & Nifty Bank 524 Points From Highs Image
#MarketAtClose | Sensex Fails To Hold 50-DMA Of 50,072, Closes 84 Points Higher At 49,746

Nifty Gains 55 Points To 14,874 & Midcap Index 129 Points To 24,462

Nifty Bank Slips 208 Points To 32,783; All Nifty Bank Constituents In The Red
#MarketAtClose | Steel Cos Surge After Brokerages Raise Estimate; JSW Steel Up 9%, Tata Steel 5%

Price Increase Reports Keep Cement Stocks Buzzing; Shree Cement Rises 5%

Strong Q4 Update Lifts Kalyan Jewellers; Titan Gains Over 3% Too Image
Read 4 tweets
8 Apr
#CNBCTV18Market | CLSA says strength of deal activity is in-line with recent commentaries by Indian IT cos Image
#CNBCTV18Market | Top large cap picks in the IT space for Macquarie are Infosys & HCL Tech Image
#CNBCTV18Market | Citi raises FY22 EBITDA estimate by 12-20% for JSW Steel, JSPL & SAIL Image
Read 5 tweets
7 Apr
#Exclusive | Srcs: Gujarat-based Supreme Ind gets nod to conduct human trials of LifeViroTreat for #COVID treatment

DCGI had recommended phase-1 clinical human trials of LifeViroTreat (for treatment based on Inhalation)

Co had submitted animal trial data to DCGI, SEC

*thread* Image
Supreme Industries application to SEC: Inhalation therapy will be given in 2 dose nebulization/ inhalation for 3 days

Therapy seems to be successful in treating all strains/ Mutants of virus.

Alert: SEC on 25th March had considered application of Supreme Industries
Supreme Ind to CNBC-TV18: Have got government approval to conduct Phase1 Human clinical trials.

Therapy has shown very safe in preclinical study results.

Phase 1 clinical trials will be initially done on 2 subjects and then it will be expanded

*thread* Image
Read 4 tweets
7 Apr
#MarketAtClose | Market Closes Higher But Off Highs; ICICI, Infosys & RIL Top Contributors

RBI’s Accommodative Stance Leads To A Gain In Bks; Nifty Bank Up Over 1.5%

Midcaps Continue To Outperform Frontliners; Mkt Breadth Favours Advances Image
#MarketAtClose | Sensex Closes 460 Pts Higher At 49,662 & Nifty 136 Pts Higher At 14,819

Nifty Bank Rises 490 Points To 32,991 & Midcap Index 317 Points To 24,333

All Sectoral Indices In the Green; PSU Bank & Auto Top Gaining Indices
#MarketAtClose | Metals Continue The Gaining Momentum; JSW Steel Top Nifty Gainer, Up 5%

Rupee Weakness Lifts IT Stocks; Nifty IT Up Over 1%

Bharti Airtel Rises 2% & RIL 1% After 800 MHz Spectrum Deal Image
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!